Market Overview

UPDATE: Jefferies Downgrades HealthSouth Corporation to Hold on Regulatory Headwinds

Related HLS
Select Medical Crafts a 52-Week High - Analyst Blog
Top 4 Stocks In The Specialized Health Services Industry With The Highest Dividend Yield

Jefferies lowered its HealthSouth Corporation (NYSE: HLS) rating from Buy to Hold and reduced its price target from $25 to $23.

Jefferies noted, "HLS's strong Q2 performance and raised guidance was impressive, but we recommend taking advantage of stock strength to lighten long positions, fearing that IRF reimbursement could get greater scrutiny later this year when legislators look for funding offsets to another doc fix and deficit reduction."

HealthSouth Corporation closed at $22.93 on Thursday.

Posted-In: JefferiesAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Most Popular

Related Articles (HLS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free